{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:15:24Z","timestamp":1773465324244,"version":"3.50.1"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.semcancer.2014.03.001","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T06:31:17Z","timestamp":1394778677000},"page":"62-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents"],"prefix":"10.1016","volume":"27","author":[{"given":"Joel G.","family":"Turner","sequence":"first","affiliation":[]},{"given":"Jana","family":"Dawson","sequence":"additional","affiliation":[]},{"given":"Christopher L.","family":"Cubitt","sequence":"additional","affiliation":[]},{"given":"Rachid","family":"Baz","sequence":"additional","affiliation":[]},{"given":"Daniel M.","family":"Sullivan","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2014.03.001_bib0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1083\/jcb.110.4.883","article-title":"Correlation between structure and mass distribution of the nuclear pore complex and of distinct pore complex components","volume":"110","author":"Reichelt","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00418-007-0371-x","article-title":"Towards reconciling structure and function in the nuclear pore complex","volume":"129","author":"Lim","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.biochem.76.052705.161529","article-title":"Structural biology of nucleocytoplasmic transport","volume":"76","author":"Cook","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0020","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1126\/science.1173388","article-title":"Crystal structure of the nuclear export receptor CRM1 in complex with Snurportin1 and RanGTP","volume":"324","author":"Monecke","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1586","article-title":"Structural basis for assembly and disassembly of the CRM1 nuclear export complex","volume":"16","author":"Dong","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0030","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1091\/mbc.E12-01-0045","article-title":"NESdb: a database of NES-containing CRM1 cargoes","volume":"23","author":"Xu","year":"2012","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0035","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1091\/mbc.E12-01-0046","article-title":"Sequence and structural analyses of nuclear export signals in the NESdb database","volume":"23","author":"Xu","year":"2012","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0040","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1073\/pnas.1217203110","article-title":"Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1","volume":"110","author":"Sun","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bcp.2011.12.016","article-title":"Nuclear export of proteins and drug resistance in cancer","volume":"83","author":"Turner","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0050","article-title":"Targeting nucleocytoplasmic transport in cancer therapy","author":"Hill","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0055","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1073\/pnas.96.16.9112","article-title":"Leptomycin B inactivates CRM1\/exportin 1 by covalent modification at a cysteine residue in the central conserved region","volume":"96","author":"Kudo","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.febslet.2004.08.056","article-title":"Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms","volume":"576","author":"Meissner","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0065","doi-asserted-by":"crossref","first-page":"A19","DOI":"10.1158\/1078-0432.TCMUSA10-A19","article-title":"KPT0127, a novel, potent and selective inhibitor of Crm1-mediated nuclear export shows selective cytoxicity for neoplastic over normal cells and is well tolerated in animals","volume":"16","author":"Shacham","year":"2010","journal-title":"Clin Can Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0070","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood-2011-01-333138","article-title":"CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity","volume":"118","author":"Sakakibara","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7150\/jca.7080","article-title":"CRM1 inhibition sensitizes drug resistant human myeloma cells to topoisomerase II and proteasome inhibitors both in vitro and ex vivo","volume":"4","author":"Turner","year":"2013","journal-title":"J Cancer"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0080","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1242\/jcs.01147","article-title":"Human topoisomerase IIalpha nuclear export is mediated by two CRM-1-dependent nuclear export signals","volume":"117","author":"Turner","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0085","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V122.21.1925.1925","article-title":"Targeting the nuclear export signal in multiple myeloma","volume":"122","author":"Turner","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0090","doi-asserted-by":"crossref","first-page":"908","DOI":"10.4161\/cc.4.7.1796","article-title":"Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins","volume":"4","author":"Vogt","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/emboj\/21.1.31","article-title":"A masked NES in INI1\/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis","volume":"21","author":"Craig","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/359235a0","article-title":"APC mutations occur early during colorectal tumorigenesis","volume":"359","author":"Powell","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1034\/j.1600-0854.2002.30601.x","article-title":"Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport","volume":"3","author":"Pichler","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.tcb.2005.01.005","article-title":"Leucine-rich nuclear-export signals: born to be weak","volume":"15","author":"Kutay","year":"2005","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0115","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1247\/csf.24.425","article-title":"Nucleocytoplasmic protein transport and recycling of Ran","volume":"24","author":"Yoneda","year":"1999","journal-title":"Cell Struct Funct"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-0854.2005.00268.x","article-title":"Regulation of nuclear transport: central role in development and transformation?","volume":"6","author":"Poon","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0125","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1126\/science.1058637","article-title":"A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation","volume":"292","author":"Zhang","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0130","doi-asserted-by":"crossref","first-page":"12132","DOI":"10.1074\/jbc.M511198200","article-title":"Phosphorylation of tyrosine 568 controls nuclear export of Nrf2","volume":"281","author":"Jain","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0135","series-title":"AACR meeting abstracts, vol. 46","first-page":"5945","article-title":"Nuclear and cytoplasmic topoisomerase II alpha are differentially phosphorylated and nuclear export is blocked by CRM1 antisense oligonucleotides","author":"Turner","year":"2005"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1242\/jcs.055475","article-title":"Casein-kinase-II-dependent phosphorylation of PPARgamma provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol","volume":"123","author":"von Knethen","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0145","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.4032.4032","article-title":"Casein kinase II modulates topoisomerase II alpha nuclear export and drug sensitivity in multiple myeloma","volume":"120","author":"Turner","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0150","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/bjc.1996.415","article-title":"Phase I trial of elactocin","volume":"74","author":"Newlands","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0155","first-page":"1440","article-title":"Phase I trial of selinexor (KPT-330), a first-in-class oral selective inhibitor of nuclear export (SINE) in patients (pts) with advanced acute myelogenous leukemia (AML)","volume":"122","author":"Garzon","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0160","first-page":"1942","article-title":"Anti tumor activity of selinexor (KPT-330), a first-in-class oral selective inhibitor of nuclear export (SINE) XPO1\/CRM1 antagonist in patients (pts) with relapsed\/refractory multiple myeloma (MM) or Waldenstrom's macroglobulinemia (WM)","volume":"122","author":"Gutierrez","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/blood.V122.21.90.90","volume":"122","author":"Gutierrez","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0170","series-title":"ASCO meeting abstracts, vol. 32","first-page":"482","article-title":"Safety and antitumor activity of selinexor (KPT-330), a first-in-class, oral XPO1 selective inhibitor of nuclear export: a phase I study expanded with colon cancer cohort","author":"Mau-Soerensen","year":"2014"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0175","series-title":"ASCO meeting abstracts, vol. 31","first-page":"2505","article-title":"First-in-class, first-in-human phase I trial of KPT-330, a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors","author":"Razak","year":"2013"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0180","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1200\/JCO.2006.10.5460","article-title":"Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression","volume":"25","author":"Orlowski","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.yexcr.2004.01.012","article-title":"The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells","volume":"295","author":"Engel","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0190","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1158\/0008-5472.CAN-09-0484","article-title":"Human multiple myeloma cells are sensitized to topoisomerase II inhibitors by CRM1 inhibition","volume":"69","author":"Turner","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0195","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1002\/cncr.26724","article-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","volume":"118","author":"Jakob","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0200","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1038\/jid.2012.233","article-title":"Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways","volume":"132","author":"Pathria","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0205","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1158\/1535-7163.MCT-12-1171","article-title":"CRM1 and BRAF inhibition synergize and induce tumor regression in BRAF-mutant melanoma","volume":"12","author":"Salas Fragomeni","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-131-3-199908030-00008","article-title":"Chronic myelogenous leukemia: biology and therapy","volume":"131","author":"Faderl","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0215","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0220","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1038\/sj.onc.1203878","article-title":"Regulation of cell death by the Abl tyrosine kinase","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0225","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/21690","article-title":"The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage","volume":"399","author":"Gong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/84683","article-title":"Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase","volume":"7","author":"Vigneri","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0235","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood-2005-05-2123","article-title":"BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B","volume":"107","author":"Aloisi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0240","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2013-04-495374","article-title":"Preclinical and clinical efficacy of XPO1\/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias","volume":"122","author":"Walker","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6004\/jnccn.2013.0005","article-title":"Induction therapy for newly diagnosed multiple myeloma","volume":"11","author":"Lonial","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0250","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/MCB.24.10.4395-4406.2004","article-title":"Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs","volume":"24","author":"Takenaka","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.09.003","article-title":"Galectin-3\u2014a jack-of-all-trades in cancer","volume":"313","author":"Newlaczyl","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0260","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.4_suppl.245","article-title":"Novel small-molecule CRM-1 inhibitor for GI cancer therapy","volume":"30","author":"Azmi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0265","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2012-1771","article-title":"KOS-2464, a novel CRM1 inhibitor and a potential drug for multiple myeloma and leukemia","volume":"72","author":"Turner","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0270","doi-asserted-by":"crossref","first-page":"916479","DOI":"10.1155\/2012\/916479","article-title":"Curability of multiple myeloma","volume":"2012","author":"Alexanian","year":"2012","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0275","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/leu.2011.196","article-title":"Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study","volume":"26","author":"Kumar","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0280","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/annonc\/mdm178","article-title":"VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek Myeloma Study Group","volume":"18","author":"Zervas","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0285","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1200\/JCO.2008.19.5370","article-title":"Phase II trial of combination therapy with bortezomib, pegylated liposomal doxorubicin, and dexamethasone in patients with newly diagnosed myeloma","volume":"27","author":"Jakubowiak","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0290","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2141.2000.01832.x","article-title":"Cell density-dependent VP-16 sensitivity of leukaemic cells is accompanied by the translocation of topoisomerase IIalpha from the nucleus to the cytoplasm","volume":"108","author":"Valkov","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0295","first-page":"48","article-title":"Drug resistance to DNA topoisomerase I and II inhibitors in human leukemia, lymphoma, and multiple myeloma","volume":"34","author":"Valkov","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0300","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nature07975","article-title":"Structural basis for leucine-rich nuclear export signal recognition by CRM1","volume":"458","author":"Dong","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0305","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1182\/blood-2012-05-429506","article-title":"Selective inhibitors of nuclear export show that CRM1\/XPO1 is a target in chronic lymphocytic leukemia","volume":"120","author":"Lapalombella","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12079-011-0121-7","article-title":"Proteasome inhibitors in cancer therapy","volume":"5","author":"Crawford","year":"2011","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0315","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0320","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00795-006-0352-5","article-title":"Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia","volume":"40","author":"Senda","year":"2007","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0325","doi-asserted-by":"crossref","first-page":"12085","DOI":"10.1073\/pnas.220401797","article-title":"Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm","volume":"97","author":"Neufeld","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0330","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/emboj\/cdg105","article-title":"Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription","volume":"22","author":"Rosin-Arbesfeld","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0335","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mc.20156","article-title":"Nuclear translocation of the pro-apoptotic Bcl-2 family member Bok induces apoptosis","volume":"45","author":"Bartholomeusz","year":"2006","journal-title":"Mol Carcinogen"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0340","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-4827(02)00019-8","article-title":"Regulation of tumor suppressors by nuclear-cytoplasmic shuttling","volume":"282","author":"Fabbro","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0345","doi-asserted-by":"crossref","first-page":"21315","DOI":"10.1074\/jbc.M200769200","article-title":"BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export","volume":"277","author":"Fabbro","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0350","doi-asserted-by":"crossref","first-page":"38589","DOI":"10.1074\/jbc.M003851200","article-title":"Identification of a functional nuclear export sequence in BRCA1","volume":"275","author":"Rodriguez","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0355","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mce.2009.01.006","article-title":"Signaling-dependent nuclear export of estradiol receptor controls cell cycle progression in breast cancer cells","volume":"308","author":"Castoria","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0360","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.steroids.2009.10.007","article-title":"Cell proliferation regulated by estradiol receptor: therapeutic implications","volume":"75","author":"Castoria","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0365","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.1128\/MCB.20.23.8969-8982.2000","article-title":"Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN","volume":"20","author":"Nakamura","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0370","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbagen.2009.07.005","article-title":"Dynamics of galectin-3 in the nucleus and cytoplasm","volume":"1800","author":"Haudek","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0375","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.4161\/cbt.8.20.9639","article-title":"Elevated expression of nuclear Hsp90 in invasive breast tumors","volume":"8","author":"Diehl","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0380","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/sj.onc.1208283","article-title":"Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin","volume":"24","author":"Muranen","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0385","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood-2005-11-4745","article-title":"Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+AML","volume":"107","author":"Falini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0390","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ajpath.2011.04.009","article-title":"An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer","volume":"179","author":"Karhemo","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0395","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/cdd.2011.79","article-title":"Nucleolar NF-kappaB\/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin","volume":"18","author":"Khandelwal","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0400","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.blre.2011.06.001","article-title":"Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?","volume":"25","author":"Falini","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0405","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1442-2050.2009.01035.x","article-title":"The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features","volume":"23","author":"Wang","year":"2010","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0410","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/me.2010-0252","article-title":"Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP","volume":"24","author":"Sanchez","year":"2010","journal-title":"Mol Endocrin"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0415","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1074\/jbc.M604672200","article-title":"Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells","volume":"282","author":"Bourguignon","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0420","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35060032","article-title":"Cytoplasmic localization of p21Cip1\/WAF1 by Akt-induced phosphorylation in HER-2\/neu-overexpressing cells","volume":"3","author":"Zhou","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0425","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/emboj\/18.5.1223","article-title":"Apoptosis inhibitory activity of cytoplasmic p21(Cip1\/WAF1) in monocytic differentiation","volume":"18","author":"Asada","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0430","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbrc.2007.04.120","article-title":"Cytoplasmic localization and ubiquitination of p21(Cip1) by reactive oxygen species","volume":"358","author":"Hwang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0435","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.1128\/MCB.25.16.7364-7374.2005","article-title":"Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153","volume":"25","author":"Rodriguez-Vilarrupla","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0440","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2141.2003.04538.x","article-title":"Bcr-Abl upregulates cytosolic p21WAF-1\/CIP-1 by a phosphoinositide-3-kinase (PI3K)-independent pathway","volume":"123","author":"Keeshan","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0445","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.4161\/cc.6.24.5087","article-title":"Multiple mechanisms for p27(Kip1) translocation and degradation","volume":"6","author":"Susaki","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0450","doi-asserted-by":"crossref","first-page":"14355","DOI":"10.1074\/jbc.C100762200","article-title":"Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export","volume":"277","author":"Ishida","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0455","doi-asserted-by":"crossref","first-page":"41355","DOI":"10.1074\/jbc.M302830200","article-title":"Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway","volume":"278","author":"Foster","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0460","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1074\/jbc.M412367200","article-title":"Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry","volume":"280","author":"Shin","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0465","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1158\/0008-5472.CAN-04-0174","article-title":"Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia","volume":"64","author":"Min","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0470","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1091\/mbc.E02-06-0319","article-title":"CRM1\/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis","volume":"14","author":"Connor","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0475","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(02)01255-2","article-title":"Parc: a cytoplasmic anchor for p53","volume":"112","author":"Nikolaev","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0480","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/excr.2002.5468","article-title":"Hsp70 family member, mot-2\/mthsp70\/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein","volume":"274","author":"Wadhwa","year":"2002","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0485","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/emboj\/18.6.1660","article-title":"A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking","volume":"18","author":"Stommel","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0490","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.drup.2003.10.004","article-title":"The importance of p53 location: nuclear or cytoplasmic zip code?","volume":"6","author":"O\u2019Brate","year":"2003","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0495","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.yexcr.2009.06.013","article-title":"Extracellular signal-regulated kinase 2 (ERK-2) mediated phosphorylation regulates nucleo-cytoplasmic shuttling and cell growth control of Ras-associated tumor suppressor protein, RASSF2","volume":"315","author":"Kumari","year":"2009","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0500","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.embor.7400824","article-title":"The Survivin\u2013Crm1 interaction is essential for chromosomal passenger complex localization and function","volume":"7","author":"Knauer","year":"2006","journal-title":"EMBO"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0505","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1096\/fj.06-5741com","article-title":"Nuclear export is essential for the tumor-promoting activity of survivin","volume":"21","author":"Knauer","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0510","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yexcr.2003.12.016","article-title":"Regulation of subcellular localization of the antiproliferative protein Tob by its nuclear export signal and bipartite nuclear localization signal sequences","volume":"295","author":"Maekawa","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0515","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/ijc.24490","article-title":"TOB suppresses breast cancer tumorigenesis","volume":"125","author":"O\u2019Malley","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0520","first-page":"1664","article-title":"Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan","volume":"56","author":"Danks","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0525","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/0008-5472.CAN-03-2915","article-title":"In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterations","volume":"64","author":"Santos","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0530","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2174\/092986708786242859","article-title":"CRM1-mediated nuclear export of proteins and drug resistance in cancer","volume":"15","author":"Turner","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0535","first-page":"5747","article-title":"Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors","volume":"60","author":"Oloumi","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0540","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1182\/blood-2012-08-447581","article-title":"Prognostic impact and targeting of CRM1 in acute myeloid leukemia","volume":"121","author":"Kojima","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0545","doi-asserted-by":"crossref","DOI":"10.1227\/01.NEU.0000348550.47441.4B","article-title":"Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis","volume":"65","author":"Shen","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0550","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.exphem.2012.09.002","article-title":"Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma","volume":"41","author":"Zhang","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0555","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1038\/leu.2013.172","article-title":"Genome-wide studies in multiple myeloma identify XPO1\/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276","volume":"27","author":"Schmidt","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0560","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3324\/haematol.2012.074781","article-title":"Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas","volume":"98","author":"Azmi","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0565","first-page":"229","article-title":"The expression of CRM1 is associated with prognosis in human osteosarcoma","volume":"21","author":"Yao","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0570","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/cncr.23354","article-title":"Expression of the nuclear export protein chromosomal region maintenance\/exportin 1\/Xpo1 is a prognostic factor in human ovarian cancer","volume":"112","author":"Noske","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0575","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2012.10.036","article-title":"Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in mice","volume":"144","author":"Azmi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0580","doi-asserted-by":"crossref","first-page":"E315","DOI":"10.25011\/cim.v32i6.10668","article-title":"Prognostic value of CRM1 in pancreas cancer","volume":"32","author":"Huang","year":"2009","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0585","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/0929867033457791","article-title":"Nucleo-cytoplasmic transport of proteins as a target for therapeutic drugs","volume":"10","author":"Yashiroda","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0590","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nrc2149","article-title":"Nuclear microenvironments in biological control and cancer","volume":"7","author":"Zaidi","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcancer.2014.03.001_bib0595","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrc1274","article-title":"Nuclear transport and cancer: from mechanism to intervention","volume":"4","author":"Kau","year":"2004","journal-title":"Nat Rev Cancer"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X14000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X14000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T05:13:42Z","timestamp":1597554822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X14000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":119,"alternative-id":["S1044579X14000376"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2014.03.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2014.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}